Generalized eruptive keratoacanthomas of Grzybowski

Background The initial patient with generalized eruptive keratoacanthomas was described by G rzybowski in 1950. The condition presents as hundreds to thousands of small (1–5 mm), flesh‐colored to erythematous papules. Objective To review the clinical characteristics and treatments of generalized eruptive keratoacanthomas of G rzybowski. Materials and methods We retrospectively reviewed the medical literature using P ub M ed, searching the terms “eruptive,” “generalized,” “ G rzybowski,” “keratoacanthoma,” and “multiple.” Patient reports and previous reviews of the subject were critically assessed and the salient features presented to the best of our knowledge. Results Generalized eruptive keratoacanthomas of G rzybowski typically present in the fifth to seventh decades of life and display an equal preponderance for both men and women. The keratoacanthomas are pruritic and predominately appear in sun‐exposed regions, such as the face (in which they often demonstrate the sign of Z orro) and the upper trunk; the tumors also show a predilection for intertriginous areas. Topical, intralesional, and systemic treatment modalities have been used; oral retinoids are considered the preferred method of treatment. Conclusion Generalized eruptive keratoacanthomas of G rzybowski is a rare form of keratoacanthoma and is considered a serious condition because the eruptions are diffuse, persistent, and recurrent. Constant pruritus, ectropion, visceral neoplasms, and unsatisfactory response to treatment are ominous prognostic factors. Successful management of this condition has been observed in patients treated with systemic retinoids, such as acitretin.